I

With the Intrarosa Savings Program, eligible commercially insured patients pay no more than $35 for each 28-day supply of Intrarosa.

Eligible patients may pay as little as $0 for their prescription of Inqovi with the Taiho Oncology Patient Support Program.

With the Injectafer Savings Program, eligible patients may pay as little as $50 on their first dose and $0 for additional doses of Injectafer.

With the Ingrezza Savings Program, commercially insured patients can pay as little as $0 per Ingrezza prescription.

With the Pfizer enCompass Co-Pay Assistance Program, eligible commercially insured patients may pay as little as $0 per prescription of Inflectra.

With the Encore Access Program, eligible commercially insured patients may pay as little as $0 co-pay per prescription of Impoyz.

Let AccessPlus help you with assistance on co-pay that exceeds $25 for your prescription to Iluvien.

Eligible patients may save a maximum of $6,800 on prescriptions of Isentress.

Most insured patients qualify to get a $0 co-pay every month on their Invokana prescriptions. The CarePath Savings Card is subject to a $3000 annual program benefit.

Patients may qualify to get a $0 co-pay every month on their Invokamet® prescriptions. The CarePath™ Savings Card is subject to a $3000 annual program benefit.